v3.25.2
Stockholders’ Equity and Redeemable Preferred Stock - Schedule of Warrants Outstanding and Exercisable (Details) - Warrant [Member]
 6 Months Ended
Jun. 30, 2025
USD ($)
$ / shares
shares
Schedule of Warrants Outstanding and Exercisable [Line Items]  
Number of Warrants, Outstanding and exercisable at beginning | shares 2,599,276
Weighted Average Exercise Price, Outstanding and exercisable at beginning | $ / shares $ 8.46
Weighted Average Remaining Life In Years, Outstanding and exercisable at beginning 4 years 6 months 10 days
Aggregate Intrinsic Value, Outstanding and exercisable at beginning | $
Number of Warrants, Issued in connection with February Offering | shares 339,559,308
Weighted Average Exercise Price, Issued in connection with February Offering | $ / shares $ 0.12
Weighted Average Remaining Life In Years, Issued in connection with February Offering 3 years 9 months
Aggregate Intrinsic Value, Issued in connection with February Offering | $
Number of Warrants, Issued pre-funded warrants | shares 22,146,750
Weighted Average Exercise Price, Issued pre-funded warrants | $ / shares
Aggregate Intrinsic Value, Issued pre-funded warrants | $
Number of Warrants, Exercise of pre-funded warrants | shares (22,146,750)
Weighted Average Exercise Price, Exercise of pre-funded warrants | $ / shares
Aggregate Intrinsic Value, Exercise of pre-funded warrants | $
Number of Warrants, Exercise of Series D Warrants from February Offering | shares (183,050,625)
Weighted Average Exercise Price,Exercise of Series D Warrants from February Offering | $ / shares $ 0.12
Aggregate Intrinsic Value, Exercise of Series D Warrants from February Offering | $
Number of Warrants, Outstanding and exercisable at Ending | shares 159,107,959
Weighted Average Exercise Price, Outstanding and exercisable at Ending | $ / shares $ 0.23
Weighted Average Remaining Life In Years, Outstanding and exercisable at Ending 4 years 6 months 3 days
Aggregate Intrinsic Value, Outstanding and exercisable at Ending | $